Medtronic, Inc. announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation.
Products
Archus Orthopedics cuts staff, scales back operations
Archus Orthopedics, a Redmond company developing reconstructive implants for spine disorders, has “substantially” reduced its headcount and scaled back operations, according to Chairman and CEO Jim Fitzsimmons.
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Invatec, a comprehensive innovator of interventional products, today announced the availability of its newly CE marked coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.
Boston Scientific Welcomes Launch of Syntax Score Website
Boston Scientific Corporation today welcomed the launch of a new website, www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score™, a novel angiographic tool used to measure the complexity of coronary artery disease.
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Medtronic, Inc., today announced that its Endeavor drug-eluting stent (DES) is the first and only coronary stent to have received CE Mark approval for treating patients with acute coronary syndrome.
Terumo Heart, Inc. Reaches Clinical Milestone with the DuraHeart™ Left Ventricular Assist System
Terumo Heart Inc. today announced reaching a critical milestone in the worldwide expansion of its DuraHeart™ Left-Ventricular Assist System (LVAS) as the 100th patient was treated with the device.
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
At six months, the NEVO™ Sirolimus-eluting Coronary Stent, incorporating RES Technology™, was superior to the Taxus® Liberte® Stent in reducing tissue growth within the stent that can potentially lead to repeat procedures, in new clinical study results released today.
Results of Medtronic-Supported implantable cardioverter-defibrillator (ICD) Clinical Trial
MVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers was applied in the MVP Trial of implantable cardioverter-defibrillator patients.
Endosense Unveils TOCCATA Trial Results: The First Complete Assessment Of Force In Catheter Ablation
Endosense has announced the release of acute clinical results from the TOCCATA (TOuCh+ for CATheter Ablation) European clinical trial at Heart Rhythm 2009, the Heart Rhythm Society’s 30th Annual Scientific Sessions in Boston, May 13 – 16.
Invatec Receives CE Mark Approval for the IN.PACT Admiral Drug Eluting Balloon
Invatec, a comprehensive innovator of interventional products, today announced the receipt of the CE Mark and the European launch of its IN.PACT™ Admiral paclitaxel-eluting PTA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.
What Is The Difference Between Hip Resurfacing And Total Hip Replacement?
If hip resurfacing is an option, the surgeon will simply reshape the damaged surface of the femoral ball and then cover it with a round metal cap. The limitation here is that the procedure only works for bone that is not too damaged by arthritis.
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
Innovative Stent Manufacturer XTENT Plans To Close Business After Failing to Find Buyer
XTENT, maker of an innovative stent that received the European CE Mark just two months ago, is closing its doors after failing to find a partner or buyer, a goal first announced in January.
Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
Smith & Nephew’s Orthopaedics business announced today it has made its first contribution to the Orthopaedic Research and Education Foundation for continuing medical education grants.
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers
St. Jude Medical, Inc. today announced European CE Mark approval of its Accent™ RF and Anthem™ RF CRT-P Pacemakers, equipped with wireless technology.
Boston Scientific to Donate Cardiac Rhythm Management Devices to Needy Patients
Boston Scientific Corporation today announced that it has agreed to donate Cardiac Rhythm Management devices to Heartbeat International, to implant in needy patients in countries outside the US.